Products
-
Retina Masterclass: How to Diagnose and Manage Vitreoretinal Disease - COPE 76541-TD (2 Hours)
CourseExpires 2025-01-18, Activity ID 123785, COPE 76541-TD (2 Hours) Optometrists often encounter patients presenting with symptoms and signs associated with a variety of vitreoretinal disease. Many conditions have different stages and severity, with diff
$50
-
Real World Applications of Deep Learning in Ocular Disease - COPE 77548-TD (1 Hours)
CourseExpires 2025-01-18, Activity ID 123785, COPE 77548-TD (1 Hours) This course will introduce deep learning and its application to posterior segment disease. The application of deep learning algorithms has the potential for improved ability to screen la
$25
-
Ocular Rosacea - A Commonly Missed Clinical Sign in Dry Eye Disease - COPE 82393-TD (1 Hours)
CourseExpires 2025-04-25, Activity ID 125303, COPE 82393-TD (1 Hours) This course will provide an overview of the epidemiology, pathophysiology and clinical signs and symptoms of ocular rosacea. It will highlight the role of immune dysregulation, genetic a
$25
-
Nutrition and the Retina - COPE 76503-TD (1 Hours)
CourseExpires 2025-01-18, Activity ID 123785, COPE 76503-TD (1 Hours) This course will enhance the practitioner''s knowledge concerning nutritional management of age-related macular degeneration, as well as insight into which nutritional supplements are be
$25
-
Innovations in Ocular Surface Disease Pipeline - COPE 82128-TD (0.5 Hours)
CourseExpires 2025-04-25, Activity ID 125303, COPE 82128-TD (0.5 Hours) This lecture will discuss current and future diagnostic and treatment options for ocular surface disease. Using case examples, participants will be provided with a perspective on manag
$25
-
Diabetic Retinopathy: An Overview of Best Diagnostic and Management Strategies - COPE 76728-TD (2 Hours)
CourseExpires 2025-01-18, Activity ID 123785, COPE 76728-TD (2 Hours) Diabetic retinopathy is one of the most common causes of blindness worldwide. There are many pitfalls that lead diabetic patients down the path of disastrous outcomes. Poor patient’s und
$50